Synthetic Methods (Schemes 1-6) S2-S9
-S6 S15-S17 137.49, 133.27, 132.37, 128.75, 127.32, 58.75, 55.77, 54.37, 53.64, 50.24, 50.04, 46.66, 46.37, 45.74, 25.65, 23.97, 19.18 51, 131.56, 129.57, 126.43, 125.59, 125.53, 123.10, 67.07, 54.29, 51.65, 48.06, 47.73, 26.11. 19 85, 53.20, 50.84, 49.33, 48.62, 48.05, 47.36, 36.31, 27.98, 26.18, 22.67, 14 .11. UV-Vis Spectroscopy. All UV-Vis spectroscopy was performed in a 6:4 HEPES Buffer to acetonitrile ratio (complexes 1 and 2) or 100% HEPES buffer (complexes 3 and 4). Data was collected from an Agilent Technologies Cary 60 UV-Vis at room temperature from 200 -1000 nm, with a fast acquisition rate. The samples were prepared and transferred to a 3mL screw top quartz cuvette inside an anaerobic chamber, with a septum cap placed on top.
Copper complex
F 3 C Cu II 2(ClO 4 -) F 3 C O CF 3 O O + (a) (b) (c) (d) (e) (f) (g)
Selectivity Studies. All selectivity studies were performed on an Agilent
Technologies Cary 60 UV-Vis at room temperature from 200-1000 nm. These studies were performed in a 6:4 HEPES buffer to acetonitrile ratio (complex 2) or 100% HEPES buffer (complex 4). 0.5 mM 2 and 4 were prepared inside a glovebag followed by different additions. For the amino acid competition studies, a 0.5 mM solution of complex 4 was prepared followed by an addition of 5 equivalents of different amino acids, and then a spectrum was acquired. Afterwards, 3 equivalents of cysteine were added and another spectrum was acquired. All of the preparation and additions were carried out inside a glovebag.
Cyclic Voltammetry (CV).
Electrochemistry experiments were carried out on a CHI 660D electrochemical workstation. Cyclic voltammetry (CV) measurements for a 1 mM solution of the compound were recorded at 100 mV/s in a glovebox. A threeelectrode cell was used, including a platinum electrode as working electrode, an Ag/Ag+ non-aqueous electrode as reference electrode (a 10 mM DMF solution of AgNO3 was used as the source of Ag+) and a platinum wire as auxiliary electrode. Bn 4 NBF 4 (0.1 M) was used as the electrolyte and the spectra were calibrated by ferrocene.
EPR Spectroscopy. EPR spectra collected from Bruker Biospin EMXplus 114 X-
band spectrometer equipped with a liquid nitrogen cryostat. The spectra of the samples were collected at room temperature. The samples were prepared in vials inside an anaerobic chamber and then transferred into 2 mm EPR tubes before acquisition. Cell uptake studies. Cell uptake studies were carried out in triplicate for complex 4 using the same conditions used for the in vitro NMR study (see below). After incubation of ~1 million HeLa cells with 0.5 mM 4, cells were washed with 5 mL PBS buffer 2 times to remove the media and 2 mL of LCIS was added. Cells were scrapped with a cell scrapper transferred to Eppendorf tubes. The tubes were centrifuged for 5 min at 0.2 rcf and the media was removed and discarded. The cell pellet so obtained was digested with 1M NaOH (1 mL) and diluted with 2% (v/v) HNO 3 (4mL). The resulting mixture was filtered by 22 μm syringe filter and the clear filtrate was subjected S12 to inductively coupled plasma-optical emission spectrometry (ICP-OES) for determination of the whole copper content. The instrument was calibrated for copper by using standard solutions with copper level of 0, 10, 25, 50, 100, 250, 500, 1000 ppb, respectively.
Cell Viability. Cell toxicity studies were conducted using an MTT assay. HeLa cells were plated into 96 well plates (~7,000 cells per well). Cells were incubated for 18 hours under normal conditions. The next day, media was taken out and the cells were washed with 100 μL of PBS two times. After incubating cells with variable concentrations of 4 following the same procedure as for the in vitro NMR study, 15 μL of MTT (5mg/mL) solution was added to each well and incubated for 2 hours. Then 100 μL of DMSO was added to dissolve the MTT crystals, the plate was placed in a shaker for 15 minutes and the absorbance was recorded using a plate reader (570 nm filter). and incubated with 1 mM of NAC for 2 hours in 8 mL DMEM medium. After this the same process as the control was followed. 19 F NMR was performed on an Agilent 400 NMR spectrometer at 376 MHz. N4 C4 C5 108.9(2) F2 C18 F1 105.1(3) N2 Cu1 N3 92.54(9) N3 C5 C4 107.5(2) F3 C18 C13 113.5(3) N4 Cu1 N3 86.16(9) N3 C6 C7 112.1(2) F2 C18 C13 112.9(2) N2 Cu1 N1 86.71(8) C6 C7 C8 114.8(2) F1 C18 C13 112.5(3) N4 Cu1 N1 94.42(9) N2 C8 C7 111.5(2) C10 N1 C1 109.4 (2) N3 Cu1 N1 177.67(9) N2 C9 C10 108.0(2) C10 N1 C11 110.4 (2) O4 Cl1 O3 110.26(13) N1 C10 C9 110.1(2) C1 N1 C11 113.7 (2) O4 Cl1 O2 109.79(13) N1 C11 C12 118.2(2) C10 N1 Cu1 103.02(15) O3 Cl1 O2 109.98(12) C17 C12 C13 116.6(2) C1 N1 Cu1 108.02(16) O4 Cl1 O1 109.01(12) C17 C12 C11 120.3(3) C11 N1 Cu1 111.81(15) O3 Cl1 O1 108.91(12) C13 C12 C11 122.9(2) C9 N2 C8 110.1 (2) O2 Cl1 O1 108.85(11) C14 C13 C12 120.8(3) C9 N2 Cu1 106.66(16) O8 Cl2 O7 109.84(12) C14 C13 C18 116.1(3) C8 N2 Cu1 117.03(17) O8 Cl2 O6 109.90(13) C12 C13 C18 122.9(2) C6 N3 C5 111.4 (2) O7 Cl2 O6 109.90(12) C15 C14 C13 120.8(3) C6 N3 Cu1 117.81(17) O8 Cl2 O5 108.74(12) C14 C15 C16 119.5(3) C5 N3 Cu1 106.71(16) O7 Cl2 O5 109.75(12) C15 C16 C17 120.1(3) C3 N4 C4 109.1 (2) O6 Cl2 O5 108.68(12) S15 (2) Cl1 O2 1.4420(11) C3 C4 1.515 (2) Cl1 O1 1.4514(10) Figure S8 . UV-Vis of complex 4 before and after amino acid addition. In red, 5 eq. of various amino acids (Glycine, histidine, threonine, serine, glutamate, aspartate, glutamine, asparagine, leucine, isoleucine, alanine, valine, and tryptophan). In blue, 5 eq. of various amino acids were added then 3 eq. of cysteine was added and incubated for 5 minutes. Basic mix contained asparagine and glutamine. Acid mix contained glutamate and aspartate. Hydrophobic mix contained leucine, isoleucine, alanine, valine, and tryptophan. 4 was dissolved in HEPES buffer to a 0.5mM concentration. 
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